25 Septembre 2017
Avelumab Approved in Europe for Merkel Cell Carcinoma
Luciano Rossetti, MD The European Commission (EC) has approved avelumab (Bavencio) for the treatment of patients with metastatic Merkel cell carcinoma, according to Merck KGaA and Pfizer, the ...
http://www.onclive.com/web-exclusives/avelumab-approved-in-europe-for-merkel-cell-carcinoma